Jeremy Rudnick - Concepedia

Author

Jeremy Rudnick

Also Known As

B. Vaillant, J Rudnick, J. D. Rudnick, J. Hu, J. Rudnick, J.D. Rudnick, Jeremy D Rudnick, Jeremy D. Rudnick, Jeremy David Rudnick, Jeremy Rudnick

117

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Cedars-Sinai Medical Center University of California San Diego The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute ImmunoCellular Therapeutics (United States)

About

Jeremy Rudnick is an author at Cedars-Sinai Medical Center specializing in medicine, oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	748
2	Cell Biology	3	3	68
3	Immunology	3	3	283
4	Health Sciences	2	2	395
5	Engineering	1	1	27

Jeremy Rudnick

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma Surasak Phuphanich, Christopher J. Wheeler, Jeremy Rudnick, Cancer Immunology Immunotherapy	2012	378
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, Science Translational Medicine ImmunologyImmunoeditingRecurrent High-grade GliomaImmunotherapeuticsHigh-grade Gliomas	2019	252
Atypical and anaplastic meningiomas treated with bevacizumab Lakshmi Nayak, Fábio M. Iwamoto, Jeremy Rudnick, Journal of Neuro-Oncology Vascular MalformationPathologyAnaplastic MeningiomasMedicinePulmonary Sclerosing Hemangioma	2012	181
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Seminars in Oncology Surgical OncologyCancer ManagementCancer RegistrationHigh-grade GliomasGlioma	2014	143
Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk Tao Sun, Rameshwar Patil, Anna Galstyan, Cancer Research	2019	77
Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era Christine Carico, Miriam Nuño, Debraj Mukherjee, PLoS ONE	2012	72
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors Marlon Garzo Saria, Courtney Corle, Jethro Hu, Journal of neurosurgery	2013	71
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas Odelia Cooper, Vivien Bonert, Jeremy Rudnick, The Journal of Clinical Endocrinology & Metabolism	2020	64
A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma Jeremy Rudnick, J. Manuel Sarmiento, Benjamin R. Uy, Journal of Clinical Neuroscience Neuro-oncologySurgical OncologyTumor InnervationMedicinePathology	2020	44
Profiles of brain metastases: Prioritization of therapeutic targets Sherise D. Ferguson, Siyuan Zheng, Joanne Xiu, International Journal of Cancer Neuro-oncologyGene AmplificationBrain MetastasesTumor HeterogeneityMedicine	2018	38

Page 1